Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $119.28 USD
Change Today -0.95 / -0.79%
Volume 517.9K
LH On Other Exchanges
As of 12:20 PM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

laboratory crp of amer hldgs (LH) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/31/15 - $131.19
52 Week Low
10/15/14 - $95.61
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

laboratory crp of amer hldgs (LH) Related Businessweek News

No Related Businessweek News Found

laboratory crp of amer hldgs (LH) Details

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. The company offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, STD tests, HCV tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by the medical profession in core testing, patient diagnosis, and in the monitoring and treatment of diseases. It also provides specialty testing services in the areas of allergy, clinical trials, diagnostic genetics, women's health, cardiovascular disease, identity, forensics, infectious disease, endocrinology, oncology, coagulation, occupational testing, and pain management. In addition, the company offers a range of early-stage and late-stage drug development services to the pharmaceutical and biotechnology industries, as well as laboratory testing services to the chemical, agrochemical, and food industries. Further, it operates an esoteric laboratory focused on personalized diagnostics for cardiovascular and metabolic disorders; and provides specialized forensic DNA analysis, proprietary DNA collection products, and relationship testing. The company provides its testing services through a sales force to the physicians, hospitals, managed care organizations, governmental agencies, employers, pharmaceutical companies, and other independent clinical laboratories. Laboratory Corporation of America Holdings has collaboration with university, hospital and academic institutions, such as Duke University, The Johns Hopkins University, the University of Minnesota, and Yale University to license and commercialize new diagnostic tests. The company was founded in 1971 and is headquartered in Burlington, North Carolina.

36,000 Employees
Last Reported Date: 02/26/15
Founded in 1971

laboratory crp of amer hldgs (LH) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $1.0M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $338.5K
Executive Vice President and Chief Executive ...
Total Annual Compensation: $632.6K
Chief Legal Officer, Chief Compliance Officer...
Total Annual Compensation: $436.1K
Senior Vice President and Chief Medical Offic...
Total Annual Compensation: $352.2K
Compensation as of Fiscal Year 2014.

laboratory crp of amer hldgs (LH) Key Developments

Laboratory Corp. of America Holdings Presents at Piper Jaffray Heartland Summit, Jun-23-2015

Laboratory Corp. of America Holdings Presents at Piper Jaffray Heartland Summit, Jun-23-2015 . Venue: Minneapolis, Minnesota, United States. Speakers: David P. King, Chairman and Chief Executive Officer.

Laboratory Corp. of America Seeks Acquisitions

Laboratory Corp. of America Holdings (NYSE:LH) is seeking acquisitions. Dave King, Chairman and Chief Executive Officer, said, "We have an undrawn revolver, we have good accumulation of cash, we do intend to continue to do the tuck-in and fold-in acquisitions that we've historically done, even through the delevering process."

LabCorp Expands Access to LabCorp AccuDraw to Support Better Patient Care

Laboratory Corporation of America Holdings announced the expanded availability of its proprietary specimen collection and handling software, LabCorpAccuDraw. Combining on-screen visual cues with step-by-step tutorials, AccuDraw is an innovative tool designed to guide the health care professional who collects patient specimens throughout the specimen collection process. AccuDrawhelps to facilitate collection and appropriate stabilization of the correct specimen type and sample volume. This technology-enabled solution leads to fewer errors in specimen collection and processing, a reduced chance of delays in testing, and a lower likelihood of having a patient undergo a second visit to a health care professional for further specimen collection. AccuDraw has been used in LabCorp's patient service centers and by LabCorp’s phlebotomists located in client locations for over five years. AccuDrawhas previously only been, and will continue to be, available to LabCorp clients through the LabCorp Beacon application. AccuDraw provides a detailed set of specimen collection and handling instructions, allowing office staff to spend more time on patient care and less time confirming the specimen collection process and requirements. On-screen visual cues are combined with detailed collection instructions to help ensure specimen and collection accuracy in the physician office. For patients and the physician office, AccuDraw provides: Improved precision and accuracy – Visual cues are customized to the specific physician test order and linked to LabCorp’s current test requirements. High-quality specimens – the guided process and clear instructions helps to ensure the quality specimen is sent to the laboratory for testing. Time efficiencies – Reduce the amount of time spent speaking to the lab about specimen requirements or identifying specimens that were not properly submitted to the lab. Reduction in repeat draws – AccuDraw’s collection, handling, and shipping guidance significantly reduces the need for patient redraws and repeat visits.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LH:US $119.28 USD -0.95

LH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cerner Corp $67.56 USD -0.67
Hologic Inc $38.37 USD +0.03
PAREXEL International Corp $64.12 USD -0.62
Quest Diagnostics Inc $70.62 USD -0.45
Sonic Healthcare Ltd A$22.76 AUD +0.40
View Industry Companies

Industry Analysis


Industry Average

Valuation LH Industry Range
Price/Earnings 26.7x
Price/Sales 1.7x
Price/Book 2.7x
Price/Cash Flow 25.0x
TEV/Sales 0.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LABORATORY CRP OF AMER HLDGS, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at